{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:30:04Z","timestamp":1793406604645,"version":"4.5.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,2,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Here we report a unique situation in which an early and synchronized Epstein-Barr virus (EBV) reactivation was induced by a 6-day course of treatment with a humanized CD3-specific monoclonal antibody in patients with recent onset of type 1 diabetes. The virologic and immunologic analysis demonstrated that this reactivation was transient, self-limited, and isolated, associated with the rapid advent of an EBV-specific T-cell response. The anti-CD3 antibody administration induced short-lasting immunosuppression and minor yet clear-cut signs of T-cell activation that preceded viral reactivation. Early posttransplant monitoring of renal and islet allograft recipients showed that no comparable phenomenon was observed after the administration of full-dose immunosuppressive therapy. This EBV reactivation remains of no apparent clinical concern over the long term and should not preclude further development of therapeutic anti-CD3 antibodies. This phenomenon may also direct new research avenues to understand the still ill-defined nature of stimuli triggering EBV reactivation in vivo.<\/jats:p>","DOI":"10.1182\/blood-2009-02-204875","type":"journal-article","created":{"date-parts":[[2009,12,10]],"date-time":"2009-12-10T03:26:59Z","timestamp":1260415619000},"page":"1145-1155","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":74,"title":["Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients"],"prefix":"10.1182","volume":"115","author":[{"given":"Bart","family":"Keymeulen","sequence":"first","affiliation":[{"name":"Academisch Ziekenhuis and Diabetes Research Center, Brussels Free University-VUB, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Candon","sequence":"additional","affiliation":[{"name":"Inserm U580, H\u00f4pital Necker-Enfants Malades, Paris, France;"},{"name":"Universit\u00e9 Paris Descartes, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Fafi-Kremer","sequence":"additional","affiliation":[{"name":"Institut de Virologie, Centre Hospitalier Universitaire (CHU), Strasbourg, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Ziegler","sequence":"additional","affiliation":[{"name":"Hospital M\u00fcnchen-Schwabing, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Leruez-Ville","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Descartes, Paris, France;"},{"name":"Laboratoire de Virologie, H\u00f4pital Necker-Enfants Malades, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, UZ Gasthuisberg, K.U.Leuven, Leuven, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evy","family":"Vandemeulebroucke","sequence":"additional","affiliation":[{"name":"Academisch Ziekenhuis and Diabetes Research Center, Brussels Free University-VUB, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Walter","sequence":"additional","affiliation":[{"name":"Hospital M\u00fcnchen-Schwabing, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Crenier","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Libre de Bruxelles, H\u00f4pital Erasme, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Thervet","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Descartes, Paris, France;"},{"name":"Service de Transplantation R\u00e9nale, H\u00f4pital Necker-Enfants Malades, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Legendre","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Descartes, Paris, France;"},{"name":"Service de Transplantation R\u00e9nale, H\u00f4pital Necker-Enfants Malades, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Pierard","sequence":"additional","affiliation":[{"name":"Academisch Ziekenhuis and Diabetes Research Center, Brussels Free University-VUB, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff","family":"Hale","sequence":"additional","affiliation":[{"name":"Sir William Dunn School of Pathology, Oxford, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Waldmann","sequence":"additional","affiliation":[{"name":"Sir William Dunn School of Pathology, Oxford, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Bach","sequence":"additional","affiliation":[{"name":"Inserm U580, H\u00f4pital Necker-Enfants Malades, Paris, France;"},{"name":"Universit\u00e9 Paris Descartes, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marie","family":"Seigneurin","sequence":"additional","affiliation":[{"name":"Laboratoire de Virologie M\u00e9dicale, CHU, Universit\u00e9 Joseph Fourier, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pipeleers","sequence":"additional","affiliation":[{"name":"Academisch Ziekenhuis and Diabetes Research Center, Brussels Free University-VUB, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucienne","family":"Chatenoud","sequence":"additional","affiliation":[{"name":"Inserm U580, H\u00f4pital Necker-Enfants Malades, Paris, France;"},{"name":"Universit\u00e9 Paris Descartes, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111722430303400_B1","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1086\/428097","article-title":"Long-term shedding of infectious Epstein-Barr virus after infectious mononucleosis.","volume":"191","author":"Fafi-Kremer","year":"2005","journal-title":"J Infect Dis"},{"issue":"1","key":"2019111722430303400_B2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2141.1995.tb08904.x","article-title":"Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease.","volume":"89","author":"Rooney","year":"1995","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111722430303400_B3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood.V97.5.1165","article-title":"Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients.","volume":"97","author":"Stevens","year":"2001","journal-title":"Blood"},{"issue":"12","key":"2019111722430303400_B4","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1182\/blood.V99.12.4364","article-title":"Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation.","volume":"99","author":"van Esser","year":"2002","journal-title":"Blood"},{"issue":"1","key":"2019111722430303400_B5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/01.TP.0000093997.83754.2B","article-title":"Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.","volume":"77","author":"Clave","year":"2004","journal-title":"Transplantation"},{"issue":"9","key":"2019111722430303400_B6","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1200\/JCO.1993.11.9.1674","article-title":"Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression.","volume":"11","author":"Carbone","year":"1993","journal-title":"J Clin Oncol"},{"issue":"8","key":"2019111722430303400_B7","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood.V98.8.2339","article-title":"Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy.","volume":"98","author":"Besson","year":"2001","journal-title":"Blood"},{"issue":"25","key":"2019111722430303400_B8","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1056\/NEJMoa043980","article-title":"Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.","volume":"352","author":"Keymeulen","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111722430303400_B9","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.4049\/jimmunol.158.6.2947","article-title":"CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice.","volume":"158","author":"Chatenoud","year":"1997","journal-title":"J Immunol"},{"issue":"1","key":"2019111722430303400_B10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1073\/pnas.91.1.123","article-title":"Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.","volume":"91","author":"Chatenoud","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2019111722430303400_B11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nri1000","article-title":"CD3-specific antibody-induced active tolerance: from bench to bedside.","volume":"3","author":"Chatenoud","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"22","key":"2019111722430303400_B12","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1056\/NEJMoa012864","article-title":"Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.","volume":"346","author":"Herold","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111722430303400_B13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/eji.1830230216","article-title":"The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties.","volume":"23","author":"Bolt","year":"1993","journal-title":"Eur J Immunol"},{"issue":"46","key":"2019111722430303400_B14","doi-asserted-by":"crossref","first-page":"17444","DOI":"10.1073\/pnas.0608141103","article-title":"Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft.","volume":"103","author":"Keymeulen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2019111722430303400_B15","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jmv.2153","article-title":"Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections.","volume":"66","author":"Brengel-Pesce","year":"2002","journal-title":"J Med Virol"},{"issue":"1","key":"2019111722430303400_B16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2353\/jmoldx.2008.070054","article-title":"Evaluation of the Epstein-Barr virus R-gene quantification kit in whole blood with different extraction methods and PCR platforms.","volume":"10","author":"Fafi-Kremer","year":"2008","journal-title":"J Mol Diagn"},{"issue":"2","key":"2019111722430303400_B17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00019606-200406000-00001","article-title":"Epstein-Barr Virus (EBV) DNA in plasma is not encapsidated in patients with EBV-related malignancies.","volume":"13","author":"Ryan","year":"2004","journal-title":"Diagn Mol Pathol"},{"issue":"1","key":"2019111722430303400_B18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jviromet.2007.02.005","article-title":"Real-time quantitative PCR for assessment of antiviral drug effects against Epstein-Barr virus replication and EBV late mRNA expression.","volume":"143","author":"Ballout","year":"2007","journal-title":"J Virol Methods"},{"issue":"7","key":"2019111722430303400_B19","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1084\/jem.20011692","article-title":"Epitope-specific evolution of human CD8(+) T-cell responses from primary to persistent phases of Epstein-Barr virus infection.","volume":"195","author":"Hislop","year":"2002","journal-title":"J Exp Med"},{"issue":"4","key":"2019111722430303400_B20","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.4049\/jimmunol.167.4.2019","article-title":"EBV-specific CD8+ T-cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function.","volume":"167","author":"Hislop","year":"2001","journal-title":"J Immunol"},{"issue":"2","key":"2019111722430303400_B21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1074-7613(00)80493-8","article-title":"Is EBV persistence in vivo a model for B-cell homeostasis?","volume":"5","author":"Khan","year":"1996","journal-title":"Immunity"},{"issue":"10","key":"2019111722430303400_B22","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1128\/JVI.78.10.5194-5204.2004","article-title":"Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells.","volume":"78","author":"Hochberg","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"2019111722430303400_B23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein-Barr virus: exploiting the immune system.","volume":"1","author":"Thorley-Lawson","year":"2001","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2019111722430303400_B24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/rmv.456","article-title":"Reactivation of Epstein-Barr virus from latency.","volume":"15","author":"Amon","year":"2005","journal-title":"Rev Med Virol"},{"issue":"1","key":"2019111722430303400_B25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-3083.1998.00371.x","article-title":"Differentiation of T lymphocytes in the human adenoid as measured by the expression of CD45 isoforms.","volume":"48","author":"Mattila","year":"1998","journal-title":"Scand J Immunol"},{"issue":"6","key":"2019111722430303400_B26","doi-asserted-by":"crossref","first-page":"e1000490","DOI":"10.1371\/journal.ppat.1000490","article-title":"Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle.","volume":"5","author":"Croft","year":"2009","journal-title":"PLoS Pathog"},{"issue":"2","key":"2019111722430303400_B27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1128\/JVI.01777-06","article-title":"The switch from latent to productive infection in Epstein-Barr virus-infected B cells is associated with sensitization to NK-cell killing.","volume":"81","author":"Pappworth","year":"2007","journal-title":"J Virol"},{"issue":"3","key":"2019111722430303400_B28","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2007-06-093278","article-title":"On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis.","volume":"111","author":"Hadinoto","year":"2008","journal-title":"Blood"},{"issue":"6","key":"2019111722430303400_B29","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2337\/diabetes.54.6.1763","article-title":"A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes.","volume":"54","author":"Herold","year":"2005","journal-title":"Diabetes"},{"issue":"10","key":"2019111722430303400_B30","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1172\/JCI23961","article-title":"TCR stimulation with modified anti-CD3 mAb expands CD8+ T-cell population and induces CD8+CD25+ Tregs.","volume":"115","author":"Bisikirska","year":"2005","journal-title":"J Clin Invest"},{"issue":"11","key":"2019111722430303400_B31","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/eji.1830121116","article-title":"Human in vivo antigenic modulation induced by the anti-T cell OKT3 monoclonal antibody.","volume":"12","author":"Chatenoud","year":"1982","journal-title":"Eur J Immunol"},{"issue":"1","key":"2019111722430303400_B32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0167-5699(84)90061-6","article-title":"Antigenic modulation\u2014a major mechanism of antibody action.","volume":"5","author":"Chatenoud","year":"1984","journal-title":"Immunol Today"},{"issue":"3","key":"2019111722430303400_B33","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4049\/jimmunol.137.3.830","article-title":"Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3.","volume":"137","author":"Chatenoud","year":"1986","journal-title":"J Immunol"},{"issue":"6","key":"2019111722430303400_B34","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/00007890-198606000-00013","article-title":"Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients. Utilization of OKT3 as the sole immunosuppressive agent.","volume":"41","author":"Vigeral","year":"1986","journal-title":"Transplantation"},{"issue":"11","key":"2019111722430303400_B35","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood-2008-05-157222","article-title":"Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients.","volume":"113","author":"Louis","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019111722430303400_B36","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/00007890-198904000-00008","article-title":"Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients.","volume":"47","author":"Abramowicz","year":"1989","journal-title":"Transplantation"},{"issue":"4","key":"2019111722430303400_B37","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00007890-199004000-00009","article-title":"In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids.","volume":"49","author":"Chatenoud","year":"1990","journal-title":"Transplantation"},{"issue":"3","key":"2019111722430303400_B38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00007890-198903000-00018","article-title":"Evidence of involvement of tumor necrosis factor in adverse reactions during treatment of kidney allograft rejection with antithymocyte globulin.","volume":"47","author":"Debets","year":"1989","journal-title":"Transplantation"},{"issue":"1","key":"2019111722430303400_B39","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1073\/pnas.221439999","article-title":"Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1.","volume":"99","author":"Adler","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"2019111722430303400_B40","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1128\/JVI.74.14.6675-6679.2000","article-title":"Functional analysis of the CD4(+) T-cell response to Epstein-Barr virus: T-cell\u2013mediated activation of resting B cells and induction of viral BZLF1 expression.","volume":"74","author":"Fu","year":"2000","journal-title":"J Virol"},{"issue":"1-2","key":"2019111722430303400_B41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.virusres.2009.05.003","article-title":"Interleukin-21 regulates expression of the immediate-early lytic cycle genes and proteins in Epstein-Barr virus infected B cells.","volume":"144","author":"Konforte","year":"2009","journal-title":"Virus Res"},{"issue":"3","key":"2019111722430303400_B42","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1086\/341460","article-title":"Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma.","volume":"186","author":"Van Baarle","year":"2002","journal-title":"J Infect Dis"},{"issue":"7","key":"2019111722430303400_B43","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/00002030-200205030-00005","article-title":"High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology.","volume":"16","author":"Stevens","year":"2002","journal-title":"AIDS"},{"issue":"3","key":"2019111722430303400_B44","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/(SICI)1096-9071(199811)56:3<186::AID-JMV2>3.0.CO;2-3","article-title":"Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.","volume":"56","author":"Aalto","year":"1998","journal-title":"J Med Virol"},{"issue":"2","key":"2019111722430303400_B45","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4049\/jimmunol.172.2.1287","article-title":"Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus.","volume":"172","author":"Kang","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"2019111722430303400_B46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1570162043485068","article-title":"B lymphocyte dysfunctions in HIV infection.","volume":"2","author":"De Milito","year":"2004","journal-title":"Curr HIV Res"},{"issue":"13","key":"2019111722430303400_B47","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1097\/00002030-200309050-00006","article-title":"Persistent immune activation in HIV-1 infection is associated with progression to AIDS.","volume":"17","author":"Hazenberg","year":"2003","journal-title":"AIDS"},{"issue":"2","key":"2019111722430303400_B48","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/infdis\/169.2.420","article-title":"Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection\u2013correlations to clinical, immunologic, and virologic parameters.","volume":"169","author":"Aukrust","year":"1994","journal-title":"J Infect Dis"},{"issue":"11","key":"2019111722430303400_B49","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.4049\/jimmunol.172.11.6931","article-title":"Altered EBV viral load setpoint after HIV seroconversion is in accordance with lack of predictive value of EBV load for the occurrence of AIDS-related non-Hodgkin lymphoma.","volume":"172","author":"Piriou","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"2019111722430303400_B50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1086\/524079","article-title":"Tight regulation of the Epstein-Barr virus setpoint: interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection.","volume":"46","author":"Piriou","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/115\/6\/1145\/1327418\/zh800610001145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/115\/6\/1145\/1327418\/zh800610001145.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T21:12:19Z","timestamp":1685221939000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/115\/6\/1145\/26908\/Transient-EpsteinBarr-virus-reactivation-in-CD3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,11]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,2,11]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2009-02-204875","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,11]]}}}